|
EVMN Evommune Inc 2044725 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-32,246,000.00 |
| Balance Sheet |
|
Current Assets
|
$204,246,000.00 |
|
Assets
|
$301,947,000.00 |
|
Current Liabilities
|
$17,487,000.00 |
|
Liabilities
|
$24,361,000.00 |
|
Equity
|
$277,586,000.00 |
|
Shares Out
|
36281767.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-47,819,000.00 |
|
Investing Cash Flow
|
$-54,065,000.00 |
| Market Analysis |
Market Cap
|
$492,343,578.19 |
|
Price
|
$9.65 |
|
BVPS
|
7.65 |
|
PB
|
1.77 |
|
EPS
|
-0.89 |
|
FCF
|
$-48,085,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:37 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:27 |
|
| Apr |
May |
Jun |
| 2026-03-05 |
-1.43 |
|
|
2026-05-07 |
-0.64 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view EVMN documents filed with the SEC.
EVMN Filings
Clear
